Yatırımcı.AI

YBTAS vs TRILC Comparison

Price, market cap, valuation, profitability and leverage metrics of YBTAS and TRILC side by side.

YBTASTRILC
StockFund

If you had invested TRY 10,000

Metric comparison

YBTAS vs TRILC Comparison
MetricYBTASTRILCSector median
Last price (TL)10.800.9118.82
Daily change0.19%1.11%−3.44%
Market capTRY 3.2BTRY 943.7MTRY 7.5B
P/E45.17—9.96
P/B1.590.470.82
Return on equity3.52%−4.59%3.00%
Free float9.82%73.16%36.51%
Ratios are calculated from the latest published financial statements.

Popular comparisons

Related pages

About the YBTAS vs TRILC comparison

Price, market cap, valuation multiples, profitability and leverage of YBTAS (Yibitas İnşaat Malzeme) and TRILC (Türk İlaç Serum) side by side as of Sep 28, 2026, 10:00. Of the 15 metrics compared, YBTAS leads in 10 and TRILC leads in 5.

Highlights: Daily change: TRILC leads (1.11% vs 0.19%). Market cap: YBTAS leads (TRY 3.2B vs TRY 943.7M). P/B: TRILC leads (0.47 vs 1.59). EV/EBITDA: TRILC leads (3.67 vs 8.49). EV/Sales: YBTAS leads (3.12 vs 3.61). Gross margin: YBTAS leads (25.89% vs 25.29%). EBITDA margin (annual): TRILC leads (27.80% vs 24.32%). Net margin (annual): YBTAS leads (3.84% vs −1.65%).

Frequently asked questions

By P/E, Tie is cheaper (45.17 vs —); by P/B, TRILC trades at the lower multiple (1.59 vs 0.47).

Annual net margin is 3.84% for YBTAS and −1.65% for TRILC; return on equity is 3.52% for YBTAS and −4.59% for TRILC.

The leverage ratio is 25.95 for YBTAS and 76.53 for TRILC; net debt/EBITDA is −0.02 for YBTAS and 2.88 for TRILC. Lower values mean less leverage.

Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.